Matches in Wikidata for { <http://www.wikidata.org/entity/Q91569712> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91569712 description "article scientifique publié en 2019" @default.
- Q91569712 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91569712 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91569712 description "scientific article published on 16 April 2019" @default.
- Q91569712 description "wetenschappelijk artikel" @default.
- Q91569712 description "наукова стаття, опублікована 16 квітня 2019" @default.
- Q91569712 name "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 name "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 type Item @default.
- Q91569712 label "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 label "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 prefLabel "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 prefLabel "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 P1433 Q91569712-2C14C2C2-E3A5-4B30-A4B1-210F290FA2B9 @default.
- Q91569712 P1476 Q91569712-615BBA9D-0CFE-4902-B47D-95517883B543 @default.
- Q91569712 P2093 Q91569712-25270A4B-B952-4A2F-BD27-58963A68B59F @default.
- Q91569712 P2093 Q91569712-25C774B1-B603-4167-A24A-9FA884BE92F9 @default.
- Q91569712 P2093 Q91569712-A843C704-0C14-489A-B9F5-907D7F396A39 @default.
- Q91569712 P2093 Q91569712-DCEDF9BE-72EE-44CA-B00E-EA65889CE0BC @default.
- Q91569712 P2093 Q91569712-E88083FA-A973-4926-9AA8-984A185D7D9E @default.
- Q91569712 P304 Q91569712-DDAE4874-F311-47A0-B521-21E172BDAC02 @default.
- Q91569712 P31 Q91569712-99E77119-1EE6-433F-8139-7BC291C2FADD @default.
- Q91569712 P356 Q91569712-9DBBB6B2-0D04-4FCF-9469-130F0931A5F5 @default.
- Q91569712 P478 Q91569712-7EE848D2-6D34-4208-90D7-C8C72BFB20F2 @default.
- Q91569712 P577 Q91569712-32E7887B-6F08-435A-A1D2-60CA7EEA267C @default.
- Q91569712 P698 Q91569712-76D51A0F-84E2-4FB2-9721-DBEA676C2B00 @default.
- Q91569712 P921 Q91569712-2415E6FB-CDF0-4370-B08D-1C3040456CEB @default.
- Q91569712 P921 Q91569712-62AF1752-4716-4192-A8A5-659A7AC63456 @default.
- Q91569712 P356 J.COLSURFB.2019.04.036 @default.
- Q91569712 P698 31030022 @default.
- Q91569712 P1433 Q2625859 @default.
- Q91569712 P1476 "Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced" @default.
- Q91569712 P2093 "Hongxia Shao" @default.
- Q91569712 P2093 "Juan Wang" @default.
- Q91569712 P2093 "Jun Gu" @default.
- Q91569712 P2093 "Xiaoli Song" @default.
- Q91569712 P2093 "Yue Xu" @default.
- Q91569712 P304 "110-117" @default.
- Q91569712 P31 Q13442814 @default.
- Q91569712 P356 "10.1016/J.COLSURFB.2019.04.036" @default.
- Q91569712 P478 "180" @default.
- Q91569712 P577 "2019-04-16T00:00:00Z" @default.
- Q91569712 P698 "31030022" @default.
- Q91569712 P921 Q623031 @default.
- Q91569712 P921 Q7739 @default.